SAMSUNG-SEMICONDUCTOR
18.11.2020 10:02:08 CET | Business Wire | Press release
Samsung Semiconductor Europe, a wholly owned subsidiary of Samsung Electronics. Co., Ltd. has announced today that the relocation of its EMEA headquarters from the Frankfurt region to Munich, a leading high-tech hub in Germany, is now completed.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118005044/en/
Aiming to be on the doorstep of many key customers and partners with whom the company is driving digital transformation across industries, Samsung Semiconductor Europe started moving into the new Bavaria Towers in early 2020. Consolidating the already existing Ismaning office along the way, the relocation process was finally completed by closing the previous location near Frankfurt by end of September.
“Faster response times to our customers and attracting the best talent in this technology hub are key for Samsung Semiconductor Europe to remain a leading solution provider for the next few decades,” said Dermot Ryan, managing director at Samsung Semiconductor Europe. “By embracing future trends like artificial intelligence (AI), 5G, internet of things (IoT), big data, cloud computing, automotive and more, we work at the chip and basic software level, not only to make our own devices more intelligent, but also to enable entire industries to become smarter. The move to Munich marks a new era for Samsung Semiconductor Europe as we embark upon a new age of innovation, cooperation and trust together with our employees, customers and partners.”
“As the state capital of Bavaria, Munich is not only an international and culturally diverse city in a beautiful environment, it is also Germany‘s foremost tech hub and one of the leading cities in digital transformation,“ says Clemens Baumgärtner, head of the Department of Labor and Economic Development, City of Munich. “Munich offers excellent infrastructure and a vibrant ecosystem of companies, universities, start-ups and professional networks to companies in the areas of high-tech, IoT and services. We are more than happy to welcome Samsung Semiconductor Europe to shape the future of our region together.”
Munich has not only a leading position within Germany’s ICT sector, with 119.000 employees and 11.300 companies in and around the area according to the Bavarian Statistical Office , it also ranks high within European ICT poles of excellence, according to a study of the European Commission .
At Bavaria Towers, Samsung Semiconductor Europe employs around 170 staff from a large variety of countries in sales and marketing for Samsung Electronics’ component business units in Europe, the Middle East and Africa along with its sales offices in Finland, France, Turkey and the UK. From a technology point of view, Samsung Semiconductor Europe provides component solutions featuring industry-leading technologies in the areas of memory, system LSI, foundry, LED and display, often setting a new standard in the industry.
The company also offers a dynamic work culture in an exciting and inspiring atmosphere. As employees’ health and safety are one of its top priorities, the company provides a variety of employee benefits for improved work-life balance and thrives on a diverse and empowering work environment.
To learn more about Samsung Semiconductor Europe, please visit https://www.linkedin.com/showcase/samsung-semi-europe/
###
About Samsung Semiconductor Europe GmbH
Samsung Semiconductor Europe, a wholly owned subsidiary of Samsung Electronics Co. Ltd., is headquartered in Munich, Germany and operates offices in Europe, Middle East and Africa (EMEA). Samsung Semiconductor's European base handles the marketing and sales of Samsung Electronics' component business units including Memory, System LSI, Foundry, LED and Display in EMEA for various applications including servers, data centres, mobile, industrial/automotive, IoT and more. For more information, please visit www.samsung.com/semiconductor .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201118005044/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Strike Europe Secures Full MiCA Authorization, Unlocking Bitcoin Services Across All 27 EU Member States30.6.2026 13:29:00 CEST | Press release
Strike is now available to millions of customers across the European Union Strike, a leading Bitcoin financial services company, today announced that its European entity, Zap (Strike) Europe Limited, has been authorized as a crypto-asset service provider by the Malta Financial Services Authority (MFSA) under the EU's Markets in Crypto-Assets Regulation (MiCA) and the Malta Markets in Crypto Assets Act (Cap. 647, laws of Malta) to provide crypto-asset services. The license enables millions of Europeans across all 27 EU member states to access Strike's suite of Bitcoin financial services under a single regulatory framework, replacing the patchwork of national regimes that previously governed the market. Strike has served eligible European customers since April 2024. The MFSA authorization makes that presence permanent and EU-wide, and positions the company among a small group of firms to complete the MiCA process to date. "Europe deserves a Bitcoin-only company focused on doing one thing
OpZira, Inc. Welcomes Scott Thielman, PhD, as Vice President of Product Development30.6.2026 13:17:00 CEST | Press release
OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced that Scott Thielman, PhD, PE, has joined the company as Vice President of Product Development, effective May 1, 2026. Dr. Thielman brings a unique connection to OpZira’s origins. As Chief Technology Officer of Product Creation Studio, he directed the product development of LumiThera’s Valeda® Light Delivery System - the breakthrough photobiomodulation therapy for dry age-related macular degeneration whose acquisition by Alcon led to the creation of OpZira. His involvement with Valeda gives him firsthand knowledge of the science, clinical vision, and engineering decisions that shaped the technology platform from which OpZira was born. For more than 25 years, Dr. Thielman has directed the development of dozens of FDA-cleared medical devices across ophthalmology, neurostimulation, dermatology, urology, and surgical instrumentation, with partners including Olympus
L&T Technology Services Launches Ainfonix™ 4.0 to Unlock Engineering Intelligence Across Process Industries30.6.2026 12:45:00 CEST | Press release
The enterprise AI platform turns millions of engineering artifacts that run a plant into accurate, decision-ready data, delivering up to 85% extraction accuracy and full, audit-ready traceability L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in Engineering Intelligence Solutions & ER&D Consulting Services, today announced the launch of Ainfonix™ 4.0, a next-generation Engineering Intelligence platform for process industries. Unveiled at EI Live, LTTS’ flagship event that brings together analysts, industry leaders and engineering experts, Ainfonix™ 4.0 marks an important step in the company’s Enterprise AI and Engineering Intelligence strategy. As industrial enterprises accelerate AI adoption, decades of engineering knowledge remain trapped in fragmented drawings, specifications and technical records across disparate systems. Without trusted and accessible engineering data, organizations struggle to realize the full value of AI, automation and digital transformation
Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients30.6.2026 12:03:00 CEST | Press release
Bonded by breakthroughs and a laser focus on their people and clients, leading independent agencies join forces to deliver accelerated commercial success through broadened medical affairs and communications, market access, and RWE/HEOR offerings; the most advanced degree holders; expanded global reach; and the best workplace culture around Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick's strength in commercial strategy, medical, creative, digital, analytics, and experience design, they can deliver an unparalleled scientific-to-
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma30.6.2026 12:00:00 CEST | Press release
Foundational BTKi BRUKINSA plus rituximab reduced the risk of progression or death by 43% versus bendamustine plus rituximab (HR=0.57; p<0.0001), meeting the primary endpoint of PFSMANGROVE is the first Phase 3 trial to advance a new chemotherapy-free standard in frontline MCL, potentially allowing patients freedom from the burden of years of infusionsFull results from MANGROVE, including efficacy and safety, will be presented at an upcoming medical meeting; global regulatory submissions are planned for 2H 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating foundational BTK inhibitor BRUKINSA® (zanubrutinib) plus rituximab versus bendamustine plus rituximab (BR) in adult patients with previously untreated mantle cell lymphoma (MCL). MANGROVE is the first Phase 3, global, randomized trial to evaluate a BTK inhibitor-based chemotherapy-
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
